1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: WSU-C-1287, NCI-T96-0003H, T96-0003
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-DM-96101, NCI-T96-0034D, T96-0034
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-8233, NCI-T96-0039H, T96-0039
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-9617, CWRU-1897, OSU-T96-0054, NCI-T96-0054D, T96-0054
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: GOG-146E
|
|
6.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: PD-958-05, NCI-V97-1208
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: Adult Sponsor: NCI Protocol IDs: GOG-126G
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 21 and under Sponsor: NCI Protocol IDs: CCG-0943
|